triazolam has been researched along with Rhabdomyolysis in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strohmaier, A | 1 |
| Friedrich, M | 1 |
1 other study available for triazolam and Rhabdomyolysis
| Article | Year |
|---|---|
[A nontraumatic compartment syndrome of both lower legs resulting from acute rhabdomyolysis].
Topics: Acute Disease; Adolescent; Alcoholic Intoxication; Compartment Syndromes; Drug Overdose; Fasciotomy; | 1991 |